EH
VRTX icon

Equitable Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Equitable Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
3,464
+1,294
+60% +$603K 0.01% 826
2025
Q4 		$984K Sell
2,170
-390
-15% -$168K 0.01% 867
2025
Q3 		$1M Buy
2,560
+323
+14% +$135K 0.01% 830
2025
Q2 		$996K Buy
2,237
+85
+4% +$39.2K 0.01% 797
2025
Q1 		$1.04M Buy
2,152
+415
+24% +$193K 0.01% 698
2024
Q4 		$699K Sell
1,737
-220
-11% -$102K 0.01% 773
2024
Q3 		$910K Buy
1,957
+318
+19% +$153K 0.01% 699
2024
Q2 		$768K Buy
1,639
+147
+10% +$63.8K 0.01% 710
2024
Q1 		$624K Buy
1,492
+85
+6% +$35.9K 0.01% 737
2023
Q4 		$573K Buy
1,407
+41
+3% +$15.1K 0.01% 728
2023
Q3 		$475K Buy
1,366
+30
+2% +$10.5K 0.01% 732
2023
Q2 		$470K Sell
1,336
-178
-12% -$60K 0.01% 720
2023
Q1 		$477K Buy
1,514
+721
+91% +$216K 0.01% 663
2022
Q4 		$229K Buy
+793
New +$242K ﹤0.01% 814
2020
Q4 		– Sell
-1,791
Closed -$487K – 704
2020
Q3 		$487K Buy
1,791
+19
+1% +$5.24K 0.01% 426
2020
Q2 		$514K Buy
+1,772
New +$480K 0.01% 397

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Equitable Holdings's VRTX Position: Q1 2026 in Review

Equitable Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 60% in Q1 2026, buying an estimated $603K and bringing the position to 3,464 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #826.

Equitable Holdings first reported a position in VRTX in Q2 2020 and has held it in 16 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Equitable Holdings held 3,464 shares of Vertex Pharmaceuticals worth $1.56M as of Q1 2026.
  • Equitable Holdings bought 1,294 Vertex Pharmaceuticals shares in Q1 2026, an estimated $603K.
  • Vertex Pharmaceuticals made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #826 holding.
  • Equitable Holdings first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 16 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.